Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, announced its financial results and operational highlights for the first quarter ended March 31, 2024.
Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, announced its financial results and operational highlights for the first quarter ended March 31, 2024.